Fact CheckerSign in

NCT06511934Recruiting

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Intuitive, Complete Neural Control of Tablet Computers for Communication

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Brief summary (registry, in English)

People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that could restore rapid and intuitive use of communication apps on tablet computers by people with paralysis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
6 (estimated)
First submitted
8 Jul 2024
Start date
22 Jul 2024
Primary completion date
30 Jul 2027
Lead sponsor
Leigh R. Hochberg, MD, PhD.
Diseases
Stroke
NCT number
NCT06511934

What you commit to

  • Study type: Interventional
  • Planned participants: 6
  • From 22 Jul 2024 to the primary completion date, 30 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Chronic oral or intravenous steroids or immunosuppressive therapy

Other illness

  • Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • Other serious disease or disorder that could seriously affect ability to participate in the study
    • (There are additional exclusion criteria)

Who the study is looking for

  • Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders
  • Complete or incomplete tetraplegia (quadriplegia)
  • Must live within a three-hour drive of the Study site
  • Prior enrollment in BrainGate2 clinical trial (NCT00912041)

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Masssachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.